venBio Partners LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001776382 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $216M (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 59.5%

Value $129M Shares 4,639,304 Est. Cost $21.23 Unrealized +13.5%

ALMS ALUMIS INC 20.8%

Value $45.09M Shares 4,619,803 Est. Cost $9.90 Unrealized -29.5%

HRMY HARMONY BIOSCIENCES HLDGS IN 8.5%

Value $18.31M Shares 489,194 Est. Cost $36.46 Unrealized -9.8%

ALXO ALX ONCOLOGY HLDGS INC 5.1%

Value $10.96M Shares 9,699,925 Est. Cost $39.31 Unrealized -96.1%

LYEL LYELL IMMUNOPHARMA INC 4.8%

Value $10.39M Shares 337,697 Est. Cost $9.11 Unrealized +145.6%

ARTV ARTIVA BIOTHERAPEUTICS INC 1.3%

Value $2.782M Shares 648,507 Est. Cost $11.59 Unrealized -67.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	4,639,304	$129M	59.5%	$21.23	+13.5%	COM	N69605108
ALMS	ALUMIS INC	4,619,803	$45.09M	20.8%	$9.90	-29.5%	COM	022307102
HRMY	HARMONY BIOSCIENCES HLDGS IN	489,194	$18.31M	8.5%	$36.46	-9.8%	COM	413197104
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$10.96M	5.1%	$39.31	-96.1%	COM	00166B105
LYEL	LYELL IMMUNOPHARMA INC	337,697	$10.39M	4.8%	$9.11	+145.6%	COM NEW	55083R203
ARTV	ARTIVA BIOTHERAPEUTICS INC	648,507	$2.782M	1.3%	$11.59	-67.4%	COM	04317A107